fda indications for semaglutide TrimRX Semaglutide GLP-1 for Effective Weight

Sokolova et al

Yet for all their effectiveness, these drugs come with significant drawbacks that limit their long-term use for many patients

Tirzepatide dosing protocol Tirzepatide follows a well-established escalation schedule refined through multiple clinical trials and years of real-world use: Weeks 1-4: 2.5 mg once weekly (starting dose) Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly (optional intermediate step) Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly (optional intermediate step) Week 21+: 15 mg once weekly (maximum dose) The starting dose of 2.5 mg is intentionally subtherapeutic

In contrast to pioglitazone, saroglitazar does not seem to correlate with weight gain and peripheral edema [66]

They can conduct a blood test or an ultrasound to confirm the pregnancy

Author Contributions SP and NK contributed equally to the work and were responsible for drafting and writing of the manuscript, searching of literature and interpreting of data